Product Description
| Brand | Abbott |
| Sample Type | Fecal |
| Pack Size | 20T |
| CAT No | 44FK30 |
BinaxNOW Influenza A & B Card is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab, nasal swab samples and nasal wash/aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.
Fast and Reliable Influenza TestingThe BinaxNOW Influenza A & B Card enables healthcare professionals to quickly detect influenza infections at the point of care. Visual results are available within 15 minutes, allowing for immediate clinical decisions and patient management. The simple design and easy-to-follow procedure reduce training needs while maintaining high specificity for accurate diagnosis.
Designed for Professional Use and PortabilityBuilt for use by trained medical staff, this portable rapid test can be deployed in clinics, hospitals, and other healthcare settings. Its compact size, single-use format, and silent manual operation make it suitable for busy environments where swift and reliable test results are necessary for efficient patient care.
FAQ's of Abbott BINAXNOW INFLUENZA A&B CARD:
Q: How is the BinaxNOW Influenza A & B Card test performed?
A: To use the test, a healthcare professional collects a nasal or nasopharyngeal swab specimen from the patient, applies it to the test card with the provided reagent, and reads the result visually after 15 minutes following the instructions included in the kit.
Q: What types of samples are compatible with this influenza test?
A: The BinaxNOW Influenza A & B Card is designed to detect antigens from nasal or nasopharyngeal swab specimens, providing flexibility based on patient condition and clinical setting.
Q: When should the test be used during influenza season?
A: The test can be administered to patients presenting with symptoms suggestive of influenza, especially during peak flu season or outbreaks, to aid timely diagnosis and treatment decisions.
Q: Where can I use this rapid influenza test?
A: This test is intended for use by healthcare professionals in clinical environments such as hospitals, clinics, emergency rooms, and doctor's offices. It is not suitable for home use.
Q: What happens after obtaining a test result on the card?
A: Once the results are visually interpreted after 15 minutes, positive or negative outcomes help guide clinical management. Dispose of the used test cards, swabs, and reagents as biohazard waste according to local regulations.
Q: What benefits does this rapid test offer over laboratory-based assays?
A: The BinaxNOW test provides fast results at the point of care without the need for laboratory equipment, facilitating immediate decisions for patient isolation, antiviral therapy, or further testing within minutes.
Q: How should the test kits be stored and what is their shelf life?
A: Store the test kits at temperatures between 2-30C (36-86F), protected from excessive moisture and freezing. Each kit has a shelf life of 18 months from the manufacturing date, as indicated on the packaging.